Still Detox provides 24/7 medically supervised opioid addiction treatment for adults in Boca Raton, Florida. Our board-certified Medical Director manages withdrawal from all opioids — fentanyl, heroin, oxycodone, hydrocodone, morphine, and methadone — using COWS-guided protocols and Medication-Assisted Treatment (MAT) including buprenorphine and naltrexone, in a private 14-bed setting adjacent to Boca Regional Hospital. Call now for a same-day assessment.
Free & confidential — takes about 60 seconds
Joint Commission Accredited
Florida DCF Licensed
LegitScript Certified
Verified by Psychology TodayOpioid use disorder (OUD) is a chronic brain condition classified by the DSM-5, defined by a problematic pattern of opioid use leading to clinically significant impairment or distress. Opioids are a class of drugs that bind to mu-opioid receptors in the brain, spinal cord, and gastrointestinal tract, producing pain relief, euphoria, and CNS depression. The class includes natural opiates (morphine, codeine), semi-synthetic opioids (heroin, oxycodone, hydrocodone, buprenorphine), fully synthetic opioids (fentanyl, tramadol, methadone), and illicitly manufactured fentanyl analogues. All produce physical dependence with chronic use as the opioid receptor system adapts and endogenous opioid production is suppressed.
Per NIDA, opioid use disorder is a treatable medical condition. The evidence-based standard of care, confirmed by the CDC and SAMHSA, is Medication-Assisted Treatment (MAT) using buprenorphine, methadone, or naltrexone alongside counseling — a combination that substantially reduces overdose mortality, treatment dropout, and criminal recidivism. Still Detox treats the full opioid class with individualized COWS-guided protocols, MAT, and the residential continuum that follows medical stabilization.
Opioid withdrawal itself is rarely directly fatal in physically healthy adults. But this clinical fact dramatically understates the danger of unsupported opioid detox. Opioid tolerance drops rapidly during even brief abstinence — within days of stopping, the dose a person previously tolerated becomes potentially lethal. Someone who attempts home detox and then relapses at their pre-detox dose is at extreme risk of fatal overdose. This post-cessation overdose pattern is the leading cause of opioid-related death and the central clinical argument for supervised detox with MAT and residential follow-through.
Per SAMHSA, inpatient or 24-hour medical care is the preferred setting for opioid detoxification. Opioid detox in isolation — without MAT and without the residential therapeutic program that follows — is not a complete treatment for opioid use disorder and does not reduce long-term mortality. The goal of clinical detox is not just physical stabilization but bridge-building to the residential program where recovery begins in earnest.
At Still Detox, every opioid client receives a COWS assessment at admission, buprenorphine induction where appropriate, daily Medical Director monitoring, and direct step-down into residential treatment — without facility transfer, new intake, or disruption to the most critical window of early recovery. See dedicated pages for fentanyl addiction, heroin addiction, and oxycodone addiction.
Opioid use disorder demands a complete clinical response: COWS-guided medical management, MAT, dual diagnosis evaluation, and the residential program that closes the post-detox overdose window.
Our Medical Director, board-certified in addiction medicine, evaluates every client within 24 hours of admission. COWS assessments drive medication decisions throughout the withdrawal window for all opioid types — from short-acting heroin to long-acting methadone.
Buprenorphine induction is available during opioid detox. Naltrexone (Vivitrol) is available after detox completion. Per NIDA and the CDC, MAT substantially reduces opioid overdose mortality. It is a component of evidence-based treatment — not a replacement for it.
Located on the University Hospital campus, adjacent to Boca Regional Hospital. Emergency services are immediately accessible — critical for clients presenting with fentanyl-adulterated supply complications or injection-related medical conditions requiring acute escalation.
Opioid detox flows directly into inpatient residential treatment on the same campus. The post-detox window, when tolerance is lowest and overdose risk is highest, is protected by inpatient residential structure — not left to willpower alone.
Every team member, from behavioral health techs through the Medical Director, is fluent in English and Spanish. Complete opioid addiction treatment services are available in Spanish.
Unlike most treatment facilities, Still Detox fully accommodates legitimate service animals during opioid addiction treatment. Dogs and cats are welcome. Recovery should never require leaving your companion behind.
People come to Still Detox at their most vulnerable. Here is what they say about the clinical care and the life they found on the other side of opioid addiction.
Opioid withdrawal timeline varies significantly based on the specific opioid's half-life and potency. Understanding this variation is clinically important: short-acting opioids such as heroin produce rapid, intense withdrawal onset within hours; long-acting opioids such as methadone may not produce symptoms for 24 to 72 hours but sustain them for weeks. COWS assessment at admission quantifies actual withdrawal severity regardless of the suspected substance.
The following comparison covers the most commonly treated opioid types at Still Detox. All timelines assume abrupt discontinuation without clinical management — the COWS-guided buprenorphine and comfort medication protocols at Still Detox substantially reduce withdrawal severity and duration across all opioid types.
| Opioid | Withdrawal Onset | Peak Severity | Acute Duration |
|---|---|---|---|
| Heroin | 8–12 hours | Days 1–3 | 5–7 days |
| Oxycodone (IR) | 8–12 hours | Days 1–3 | 5–7 days |
| Hydrocodone (IR) | 8–12 hours | Days 1–3 | 5–7 days |
| Fentanyl (IR) | 12–30 hours | Days 2–4 | 7–10 days |
| Fentanyl (patch) | 24–36 hours | Days 3–5 | 10–14 days |
| OxyContin / Oxycodone ER | 12–24 hours | Days 2–4 | 7–10 days |
| Morphine | 6–12 hours | Days 1–3 | 5–7 days |
| Methadone | 24–72 hours | Days 4–6 | 2–4+ weeks |
| Tramadol | 12–24 hours | Days 2–4 | 7–10 days; atypical symptoms possible |
Post-acute withdrawal syndrome (PAWS) can extend psychological symptoms including depression, anxiety, insomnia, and cravings for weeks to months after acute resolution regardless of the specific opioid.
Still Detox manages withdrawal from all opioid types with individualized COWS-guided protocols. Each taper and comfort care plan is calibrated to the specific opioid, dose, duration of use, and individual clinical presentation.
These opioids produce withdrawal onset within 6 to 24 hours of the last dose and peak within 1 to 3 days. They carry the highest immediate post-cessation overdose risk due to rapid tolerance loss.
These opioids produce delayed withdrawal onset but a more extended course. Methadone withdrawal in particular can last 2 to 4 weeks and requires modified clinical management distinct from shorter-acting opioid protocols.
Knowing what to expect removes one of the biggest barriers to making the call. Here is how opioid addiction treatment at Still Detox works from first contact through residential care.
Your admissions representative gathers your opioid use history, specific drug, current dose, and co-occurring conditions. Out-of-network PPO benefits are verified before you commit. Travel and logistics are coordinated before your arrival.
A pre-admission call within three days of arrival covers your full opioid history, psychiatric history, prior MAT experience, and any co-occurring depression, anxiety, chronic pain, or trauma — so the team and MAT plan are ready on day one.
A nurse and behavioral health tech meet you together. COWS assessment begins promptly. Buprenorphine induction and comfort medications are available immediately to prevent acute withdrawal from progressing to peak intensity without clinical support. Urine toxicology identifies the actual substances present.
Within 24 hours, the Medical Director completes a full history and physical. MAT decisions — buprenorphine dosing, naltrexone candidacy, methadone management strategy — are established based on your specific opioid, clinical history, and individual presentation.
COWS assessments guide medication adjustments throughout the acute window. Comfort medications address nausea, diarrhea, muscle pain, insomnia, and elevated vital signs. Buprenorphine manages cravings and residual withdrawal. Typical stay is 7 to 10 days, longer for methadone or fentanyl patch cases.
After stabilization, you step directly into residential treatment on the same campus. MAT continues. The psychological drivers of opioid use disorder are addressed in the program that begins where detox ends — without transfer or disruption.
The DSM-5 classifies opioid use disorder using 11 diagnostic criteria applied uniformly across all opioid types. A diagnosis requires 2 or more criteria in a 12-month period. Mild is 2 to 3; moderate is 4 to 5; severe is 6 or more. Per NIDA, opioid use disorder is a treatable chronic medical condition.
Using opioids in larger amounts or over longer periods than planned. The rapid tolerance development that characterizes opioid dependence drives dose escalation — the therapeutic dose quickly becomes insufficient to prevent withdrawal, creating a cycle of increasing use.
A persistent desire to reduce or stop opioid use combined with repeated unsuccessful attempts. The severity of opioid withdrawal — beginning within hours of the last dose for short-acting opioids — makes self-cessation feel physically impossible without clinical support for most people with significant physical dependence.
Spending significant time obtaining opioids, using them, or recovering from their effects. The compressed dosing cycle required to prevent withdrawal, combined with the time needed to maintain supply, progressively displaces all other daily functions.
A powerful urge to use opioids, frequently triggered by early withdrawal symptoms, environmental cues, or emotional distress. Opioid cravings are neurobiological — the mu-opioid receptor system, deprived of its agonist, signals urgently for relief in ways that override rational decision-making.
Opioid use that interferes with work performance, family responsibilities, or daily obligations. The cycle of opioid intoxication, withdrawal management, and supply maintenance progressively eliminates the capacity for reliable functioning.
Persisting with opioid use despite ongoing conflict with family members or partners caused or worsened by the drug. Secrecy, dishonesty, financial instability, and the behavioral consequences of opioid use disorder cause profound and often lasting relationship damage.
Giving up hobbies, social engagement, or previously valued pursuits in order to use opioids or to manage the withdrawal-dosing cycle. Life progressively narrows to a single consuming focus on opioid supply and administration.
Using opioids while driving, combining with benzodiazepines or alcohol (dramatically increasing respiratory depression and overdose risk), or using illicitly manufactured fentanyl with unknown potency. The combination of opioids with benzodiazepines is responsible for a substantial proportion of overdose deaths and is flagged in FDA black box warnings on both drug classes.
Persisting with opioid use despite awareness of physical harm including overdose history, respiratory depression episodes, opioid-induced hyperalgesia, hormonal disruption, immune suppression, or for injection users, endocarditis, HIV exposure, and hepatitis C transmission.
Requiring significantly larger opioid doses to achieve the same effect, or finding that the same dose produces a markedly diminished response. Tolerance reflects mu-opioid receptor downregulation and drives dose escalation — creating the dangerous narrowing between the effective dose and the lethal dose that characterizes severe opioid use disorder.
Experiencing muscle and bone pain, sweating, goosebumps, insomnia, nausea, vomiting, diarrhea, elevated heart rate, and intense cravings when opioids are delayed or stopped. The presence of withdrawal symptoms — and the fear of them — drives continued use and makes self-cessation neurologically and physically extremely difficult without the COWS-guided clinical management that Still Detox provides.
Source: DSM-5 opioid use disorder criteria. Per NIDA, OUD is a treatable chronic medical condition. MAT with buprenorphine or naltrexone is the evidence-based first-line treatment. Call now to start.
Talk to Admissions ConfidentiallyThese are real before-and-after moments from people who completed treatment at Still Detox and built lasting recovery. Each one represents a life that opioids did not take — and a future that treatment and MAT made possible.
Opioid tolerance drops rapidly — within days — during abstinence. Someone who stops opioids for a week and then relapses at their pre-detox dose is no longer tolerant to that dose and faces a dramatically elevated risk of fatal overdose. This tolerance-loss overdose pattern is one of the leading causes of opioid death, and the primary reason that opioid detox without MAT and residential follow-through does not reduce long-term mortality.
IMF now contaminates most illicit opioid supplies including heroin, counterfeit pills, and other street drugs. Every relapse after detox into an illicit supply therefore carries compounded risk: reduced tolerance from abstinence plus potential fentanyl exposure at unknown concentrations. There is no "safe" relapse into the current illicit opioid market.
Opioid use disorder co-occurs with depression, anxiety, PTSD, and chronic pain at high rates. Stopping opioids without treating the underlying condition means those conditions return in full force — often more severely, given PAWS — and the neurological pressure toward relapse during the highest-risk post-detox window is not managed without residential therapeutic support.
Still Detox is an out-of-network provider for most insurance plans. Many clients with PPO plans that carry out-of-network benefits apply that coverage toward opioid detox, MAT, and residential treatment. Our admissions team verifies your specific benefits at no cost and with no obligation before admission.
We confirm what your plan covers, walk through any out-of-pocket responsibility, and explain flexible payment options including monthly payment plans and promissory arrangements. Cost should never be the reason someone does not receive opioid addiction treatment.
Don't see your plan? Call us. Our specialists work with many coverage scenarios and will give you an honest answer about what is covered.
Opioid withdrawal produces significant physical suffering. Our facility pairs hospital-adjacent clinical infrastructure with an environment designed to make the most difficult days of recovery as manageable as clinically possible.
Still Detox accepts pregnancies through the second trimester with appropriate medical monitoring for both mother and fetus during opioid withdrawal. MAT with buprenorphine is safe and recommended during pregnancy per ACOG guidelines. Most facilities refuse even the first trimester.
Experience managing opioid detox in clients with chronic pain conditions, liver disease, cardiovascular compromise, injection-related infections (endocarditis, abscesses), HIV, hepatitis C, and age-related complex medical needs. The hospital-adjacent setting provides the clinical infrastructure these cases require.
Methadone withdrawal follows a significantly longer timeline than other opioids and requires modified clinical management. Still Detox manages methadone detox alongside simultaneous withdrawal from benzodiazepines, alcohol, or other substances under physician supervision.
Opioid use disorder is treatable. The window between wanting to stop and the next fatal relapse can be very short — especially with fentanyl in the supply. Our team is on-site 24 hours a day, same-day assessments are available now, and the residential care that protects against post-detox overdose begins immediately after stabilization. Call now.
We're here 24/7. Speak with admissions, confidentially and with no obligation.
☎ Call (561) 556-2677Accreditations & Memberships
We understand that there are no shortcuts on the path to recovery, and our compassionate team offers unwavering support and intensive care throughout your healing journey.
Still Detox is a member of Still Behavioral Health Group.
Get Help Now
If you or someone you care about is seeking support for substance abuse and addiction challenges, we are here to offer our assistance. This is where your journey towards healing begins.
© 2026 | Still Detox Drug and Alcohol Treatment Center in Florida
950 NW 9th CT, Boca Raton, FL 33486
